List of works - Clive Holmes

Previous psychiatric history as a risk factor for late-life dementia: a population-based case-control study

scientific article published in March 1998

A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies.

scientific article published in May 2002

Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.

scientific article

Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels.

scientific article

Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial).

scientific article published on 13 October 2016

Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.

scientific article published in May 2017

No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder

scientific article published in December 2001

Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.

scientific article published in April 2007

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.

scientific article published in November 2007

Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β.

scientific article published in June 2015

AD2000: design and conclusions.

scientific article published in October 2004

DOWNREGULATED APOPTOSIS AND AUTOPHAGY AFTER ANTI-Aβ IMMUNOTHERAPY IN ALZHEIMER'S DISEASE.

scientific article

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

scientific article published on 03 April 2019

Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

article

The clinical phenotype of familial and sporadic late onset Alzheimer's disease

scientific article

Inflammation and dementia: Using rheumatoid arthritis as a model to develop treatments?

scientific article published on 10 July 2018

Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease

article

Proinflammatory cytokines and the clinical features of dementia with lewy bodies.

scientific article published in January 2015

Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

scholarly article published in Nature Genetics

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 01 September 2019

The influence of TNF inhibitors on dementia incidence in patients with rheumatoid arthritis; an analysis from the BSRBR-RA.

scientific article published in March 2018

Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease.

scientific article

Amyloid-β vaccination for Alzheimer's dementia – Authors' reply

scientific article published in The Lancet

Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment

scientific article published on 24 May 2019

Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.

scientific article published on 30 July 2018

List of works by Clive Holmes

Previous psychiatric history as a risk factor for late-life dementia: a population-based case-control study

A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies.

Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.

Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels.

Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial).

Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.

No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder

Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.

Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β.

AD2000: design and conclusions.

DOWNREGULATED APOPTOSIS AND AUTOPHAGY AFTER ANTI-Aβ IMMUNOTHERAPY IN ALZHEIMER'S DISEASE.

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

The clinical phenotype of familial and sporadic late onset Alzheimer's disease

Inflammation and dementia: Using rheumatoid arthritis as a model to develop treatments?

Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease

Proinflammatory cytokines and the clinical features of dementia with lewy bodies.

Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

The influence of TNF inhibitors on dementia incidence in patients with rheumatoid arthritis; an analysis from the BSRBR-RA.

Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease.

Amyloid-β vaccination for Alzheimer's dementia – Authors' reply

Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment

Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.

Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as novel risk factors for Alzheimer’s Disease